Login
$DOCS
$32.77 +$0.00 (0.0%) After hours

$DOCS 8-K SEC Filings

Filed On Filing
05 Nov 2026 8-K: Results of Operations and Financial Condition

SAN FRANCISCO, Calif., November 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 second quarter ended September 30, 2026.

02 Sep 2026 8-K: Submission of Matters to a Vote of Security Holders

On August 27, 2026, Doximity, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Company’s definitive p...

06 Aug 2026 8-K: Results of Operations and Financial Condition

SAN FRANCISCO, Calif., August 6, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026.

13 May 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation

Fiscal year 2026 total revenues of $644.9 million, up 13% year-over-year

17 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

As previously disclosed by Doximity, Inc. (the “Company”) on February 5, 2026, Anna Bryson, the Company’s Chief Financial Officer, had been on medical leave. On April 13, 2026, the Company accepted her resignation as Chief Financial Offi...

05 Feb 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation

SAN FRANCISCO, Calif., February 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025.

30 Dec 2025 8-K: Other Events

As previously reported, Doximity, Inc. (“Doximity” or the “Company”) and certain company directors and officers have been named as defendants in a securities litigation lawsuit (“Securities Litigation”) pending in the United States Distr...

06 Nov 2025 8-K: Results of Operations and Financial Condition

SAN FRANCISCO, Calif., November 6, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025.

02 Sep 2025 8-K: Submission of Matters to a Vote of Security Holders

On August 28, 2025, Doximity, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Company’s definitive p...

15 Aug 2025 8-K: Departure/Election of Directors or Officers; Compensation

On August 13, 2025, Doximity determined that Jennifer Chaloemtiarana, its General Counsel, Corporate Secretary, and Chief Compliance Officer, will step down from those roles effective August 29, 2025. John Vaughan will assume all three p...

07 Aug 2025 8-K: Results of Operations and Financial Condition

SAN FRANCISCO, Calif., August 7, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025.

13 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

After 15 wonderful years, our co-founder, partner, and pyramid topper (!), Dr. Nate Gross is moving on. He’ll remain an advisor here at Doximity, but not in a day-to-day role. We will miss him.

15 May 2025 8-K: Results of Operations and Financial Condition

Q4 operating cash flow of $98.5 million, up 54% year-over-year

06 Feb 2025 8-K: Results of Operations and Financial Condition

Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year

07 Nov 2024 8-K: Results of Operations and Financial Condition

Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year

30 Aug 2024 8-K: Submission of Matters to a Vote of Security Holders

On August 29, 2024, Doximity, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Company’s definitive p...

08 Aug 2024 8-K: Results of Operations and Financial Condition

Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year

16 May 2024 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year

08 Feb 2024 8-K: Results of Operations and Financial Condition

Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year

09 Nov 2023 8-K: Results of Operations and Financial Condition

Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support